|
|
News for Healthier Living
Drug From Stony Brook-Developed Anti-Cancer Compounds Now in Clinical Trials
A promising new cancer chemotherapeutic agent from a taxane class of natural compounds - anti-cancer agents designed to block cell division and trigger the programmed cell death to treat sold tumors - originally developed by researchers at Stony Brook University has entered human clinical trials.
November 5, 2026
November 5 2026November 4 2026November 3 2026November 2 2026November 1 2026October 30 2026October 29 2026October 28 2026October 27 2026October 26 2026October 25 2026October 24 2026October 23 2026
|
|
|
|
|